New combination product represents a highly effective approach to acne vulgaris Feb. 23, 1999 No Comments
Available for licensing from VUFB: dopamine agonist for dermatology, gastrointestinal indications Feb. 19, 1999 No Comments
Fresenius will distribute Genzyme's Sepra products in select European markets Feb. 17, 1999 No Comments
Human Genome Sciences initiates phase II clinical trials of new wound-healing agent Feb. 15, 1999 No Comments
RSS